Provider: Nature Publishing Group Content: application/x-research-info-systems TY - JOUR AU - Chambers, T. J. TI - Regulation of the differentiation and function of osteoclasts JA - J. Pathol. PY - 2000/// VL - 192 SP - 4 EP - 13 M3 - 10.1002/1096-9896(2000)9999:9999<::AID-PATH645>3.3.CO;2-H N1 - 10.1002/1096-9896(2000)9999:9999<::AID-PATH645>3.3.CO;2-H UR - http://dx.doi.org/10.1002/1096-9896(2000)9999:9999<::AID-PATH645>3.3.CO;2-H ER - TY - JOUR AU - Teitlelbaum, S. L. TI - Bone resorption by osteoclasts JA - Science PY - 2000/// VL - 289 SP - 1504 EP - 1508 M3 - 10.1126/science.289.5484.1504 N1 - 10.1126/science.289.5484.1504 UR - http://dx.doi.org/10.1126/science.289.5484.1504 ER - TY - JOUR AU - Rodan, G. A. AU - Martin, T. J. TI - Therapeutic approaches to bone diseases JA - Science PY - 2000/// VL - 289 SP - 1508 EP - 1514 M3 - 10.1126/science.289.5484.1508 N1 - 10.1126/science.289.5484.1508 UR - http://dx.doi.org/10.1126/science.289.5484.1508 ER - TY - JOUR AU - Khosla, S. TI - Minireview: the OPG/RANKL/RANK system JA - Endocrinology PY - 2001/// VL - 142 SP - 5050 EP - 5055 M3 - 10.1210/en.142.12.5050 N1 - 10.1210/en.142.12.5050 UR - http://dx.doi.org/10.1210/en.142.12.5050 ER - TY - JOUR AU - Takahashi, N. TI - Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures JA - Endocrinology PY - 1988/// VL - 122 SP - 1373 EP - 1382 ER - TY - JOUR AU - Yasuda, H. TI - Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL JA - Proc. Natl Acad. Sci. USA PY - 1998/// VL - 95 SP - 3597 EP - 3602 M3 - 10.1073/pnas.95.7.3597 N1 - 10.1073/pnas.95.7.3597 UR - http://dx.doi.org/10.1073/pnas.95.7.3597 ER - TY - JOUR AU - Lacey, D. L. TI - Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation JA - Cell PY - 1998/// VL - 93 SP - 165 EP - 176 M3 - 10.1016/S0092-8674(00)81569-X N1 - 10.1016/S0092-8674(00)81569-X UR - http://dx.doi.org/10.1016/S0092-8674(00)81569-X ER - TY - JOUR AU - Nakagawa, N. TI - RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis JA - Biochem. Biophys. Res. Commun. PY - 1998/// VL - 253 SP - 395 EP - 400 M3 - 10.1006/bbrc.1998.9788 N1 - 10.1006/bbrc.1998.9788 UR - http://dx.doi.org/10.1006/bbrc.1998.9788 ER - TY - JOUR AU - Hsu, H. TI - Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand JA - Proc. Natl Acad. Sci. USA PY - 1999/// VL - 96 SP - 3540 EP - 3545 M3 - 10.1073/pnas.96.7.3540 N1 - 10.1073/pnas.96.7.3540 UR - http://dx.doi.org/10.1073/pnas.96.7.3540 ER - TY - JOUR AU - Burgess, T. L. TI - The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts JA - J. Cell Biol. PY - 1999/// VL - 145 SP - 527 EP - 538 M3 - 10.1083/jcb.145.3.527 N1 - 10.1083/jcb.145.3.527 UR - http://dx.doi.org/10.1083/jcb.145.3.527 ER - TY - JOUR AU - Li, Y. P. AU - Chen, W. AU - Liang, Y. AU - Li, E. AU - Stashenko, P. TI - Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification JA - Nature Genet. PY - 1999/// VL - 23 SP - 447 EP - 451 M3 - 10.1038/70563 N1 - 10.1038/70563 UR - http://dx.doi.org/10.1038/70563 ER - TY - JOUR AU - Fuller, K. AU - Murphy, C. AU - Kirstein, B. AU - Fox, S.W. AU - Chambers, T. J. TI - TNF[alpha] potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL JA - Endocrinology PY - 2002/// VL - 143 SP - 1108 EP - 1118 M3 - 10.1210/en.143.3.1108 N1 - 10.1210/en.143.3.1108 UR - http://dx.doi.org/10.1210/en.143.3.1108 ER - TY - JOUR AU - Rodan, G. A. TI - Bone homeostasis JA - Proc. Natl Acad. Sci. USA PY - 1998/// VL - 95 SP - 13361 EP - 13362 M3 - 10.1073/pnas.95.23.13361 N1 - 10.1073/pnas.95.23.13361 UR - http://dx.doi.org/10.1073/pnas.95.23.13361 ER - TY - JOUR AU - Jimi, E. TI - Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function JA - J. Immunol. PY - 1999/// VL - 163 SP - 434 EP - 442 ER - TY - JOUR AU - Lacey, D. L. TI - Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo JA - Am. J. Pathol. PY - 2000/// VL - 157 SP - 435 EP - 448 ER - TY - JOUR AU - Marks, S. C., TI - Osteoclast biology: lessons from mammalian mutations JA - Am. J. Med. Genet. PY - 1989/// VL - 34 SP - 43 EP - 53 ER - TY - JOUR AU - McLean, W. AU - Olsen, B. R. TI - Mouse models of abnormal skeletal development and homeostasis JA - Trends Genet. PY - 2001/// VL - 17 SP - S38 EP - S43 M3 - 10.1016/S0168-9525(01)02458-1 N1 - 10.1016/S0168-9525(01)02458-1 UR - http://dx.doi.org/10.1016/S0168-9525(01)02458-1 ER - TY - JOUR AU - Van Wesenbeeck, L. TI - The osteopetrotic mutation toothless (tl) is a loss-of-function frameshift mutation in the rat Csf1 gene: evidence of a crucial role for CSF-1 in osteoclastogenesis and endochondral ossification JA - Proc. Natl Acad. Sci. USA PY - 2002/// VL - 99 SP - 14303 EP - 14308 M3 - 10.1073/pnas.202332999 N1 - 10.1073/pnas.202332999 UR - http://dx.doi.org/10.1073/pnas.202332999 ER - TY - JOUR AU - Takeshita, S. TI - SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts JA - Nature Med. PY - 2002/// VL - 9 SP - 943 EP - 949 M3 - 10.1038/nm752 N1 - 10.1038/nm752 UR - http://dx.doi.org/10.1038/nm752 ER - TY - JOUR AU - Bucay, N. TI - Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification JA - Genes Dev. PY - 1998/// VL - 12 SP - 1260 EP - 1268 ER - TY - JOUR AU - Wagner, E. F. AU - Karsenty, G. TI - Genetic control of skeletal development JA - Curr. Opin. Genet. Dev. PY - 2001/// VL - 5 SP - 527 EP - 532 M3 - 10.1016/S0959-437X(00)00228-8 N1 - 10.1016/S0959-437X(00)00228-8 UR - http://dx.doi.org/10.1016/S0959-437X(00)00228-8 ER - TY - JOUR AU - Simonet, W. S. TI - Osteoprotegerin: a novel secreted protein involved in the regulation of bone density JA - Cell PY - 1997/// VL - 89 SP - 309 EP - 319 M3 - 10.1016/S0092-8674(00)80209-3 N1 - 10.1016/S0092-8674(00)80209-3 UR - http://dx.doi.org/10.1016/S0092-8674(00)80209-3 ER - TY - JOUR AU - Yasuda, H. TI - Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro JA - Endocrinology PY - 1998/// VL - 139 SP - 1329 EP - 1337 M3 - 10.1210/en.139.3.1329 N1 - 10.1210/en.139.3.1329 UR - http://dx.doi.org/10.1210/en.139.3.1329 ER - TY - JOUR AU - Morony, S. TI - A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1[beta], TNF-[alpha], PTH, PTHrP, and 1,25(OH)2D3 JA - J. Bone Miner. Res. PY - 1999/// VL - 14 SP - 1478 EP - 1485 ER - TY - JOUR AU - Wong, B. R. TI - TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-jun N-terminal kinase in T cells JA - J. Biol. Chem. PY - 1997/// VL - 272 SP - 25190 M3 - 10.1074/jbc.272.40.25190 N1 - 10.1074/jbc.272.40.25190 UR - http://dx.doi.org/10.1074/jbc.272.40.25190 ER - TY - JOUR AU - Anderson, D. M. TI - A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function JA - Nature PY - 1997/// VL - 390 SP - 175 EP - 179 M3 - 10.1038/36593 N1 - 10.1038/36593 UR - http://dx.doi.org/10.1038/36593 ER - TY - JOUR AU - Li, J. TI - RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism JA - Proc. Natl Acad. Sci. USA PY - 2000/// VL - 97 SP - 1566 EP - 1571 M3 - 10.1073/pnas.97.4.1566 N1 - 10.1073/pnas.97.4.1566 UR - http://dx.doi.org/10.1073/pnas.97.4.1566 ER - TY - JOUR AU - Dougall, W. C. TI - RANK is essential for osteoclast and lymph node development JA - Genes Dev. PY - 1999/// VL - 13 SP - 2412 EP - 2424 M3 - 10.1101/gad.13.18.2412 N1 - 10.1101/gad.13.18.2412 UR - http://dx.doi.org/10.1101/gad.13.18.2412 ER - TY - JOUR AU - Kong, Y. Y. TI - OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis JA - Nature PY - 1999/// VL - 397 SP - 315 EP - 323 M3 - 10.1038/16852 N1 - 10.1038/16852 UR - http://dx.doi.org/10.1038/16852 ER - TY - JOUR AU - Hofbauer, L. C. TI - The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption JA - J. Bone Miner. Res. PY - 2000/// VL - 15 SP - 2 EP - 12 ER - TY - JOUR AU - Theill, L. E. AU - Boyle, W. J. AU - Penninger, J. M. TI - RANK-L and RANK: T cells, bone loss, and mammalian evolution JA - Annu. Rev. Immunol. PY - 2002/// VL - 20 SP - 795 EP - 823 M3 - 10.1146/annurev.immunol.20.100301.064753 N1 - 10.1146/annurev.immunol.20.100301.064753 UR - http://dx.doi.org/10.1146/annurev.immunol.20.100301.064753 ER - TY - JOUR AU - Udagawa, N. TI - Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function JA - Endocrinology PY - 2000/// VL - 141 SP - 3478 EP - 3484 M3 - 10.1210/en.141.9.3478 N1 - 10.1210/en.141.9.3478 UR - http://dx.doi.org/10.1210/en.141.9.3478 ER - TY - JOUR AU - Schoppet, M. AU - Preissner, K. T. AU - Hofbauer, L. C. TI - RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function JA - Arterioscler. Thromb. Vasc. Biol. PY - 2002/// VL - 22 SP - 549 EP - 553 M3 - 10.1161/01.ATV.0000012303.37971.DA N1 - 10.1161/01.ATV.0000012303.37971.DA UR - http://dx.doi.org/10.1161/01.ATV.0000012303.37971.DA ER - TY - JOUR AU - Darnay, B. G. AU - Haridas, V. AU - Ni, J. AU - Moore, P. A. AU - Aggarwal, B. B. TI - Characterization of the intracellular domain of receptor activator of NF-[kappa]B (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-[kappa]B and c-Jun N-terminal kinase JA - J. Biol. Chem. PY - 1998/// VL - 273 SP - 20551 EP - 20555 M3 - 10.1074/jbc.273.32.20551 N1 - 10.1074/jbc.273.32.20551 UR - http://dx.doi.org/10.1074/jbc.273.32.20551 ER - TY - JOUR AU - Galibert, L. AU - Tometsko, M. E. AU - Anderson, D. M. AU - Cosman, D. AU - Dougall, W. C. TI - The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-[kappa]B, a member of the TNFR superfamily JA - J. Biol. Chem. PY - 1998/// VL - 273 SP - 34120 EP - 34127 M3 - 10.1074/jbc.273.51.34120 N1 - 10.1074/jbc.273.51.34120 UR - http://dx.doi.org/10.1074/jbc.273.51.34120 ER - TY - JOUR AU - Lomaga, M. A. TI - TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling JA - Genes Dev. PY - 1999/// VL - 13 SP - 1015 EP - 1024 ER - TY - JOUR AU - Kobayashi, N. TI - Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis JA - EMBO J. PY - 2001/// VL - 20 SP - 1271 EP - 1280 M3 - 10.1093/emboj/20.6.1271 N1 - 10.1093/emboj/20.6.1271 UR - http://dx.doi.org/10.1093/emboj/20.6.1271 ER - TY - JOUR AU - Armstrong, A. P. TI - A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function JA - J. Biol. Chem. PY - 2002/// VL - 277 SP - 44347 EP - 44356 M3 - 10.1074/jbc.M202009200 N1 - 10.1074/jbc.M202009200 UR - http://dx.doi.org/10.1074/jbc.M202009200 ER - TY - JOUR AU - Ye, H. TI - Distinct molecular mechanism for initiating TRAF6 signalling JA - Nature PY - 2002/// VL - 418 SP - 443 EP - 447 M3 - 10.1038/nature00888 N1 - 10.1038/nature00888 UR - http://dx.doi.org/10.1038/nature00888 ER - TY - JOUR AU - Franzoso, G. TI - Requirement for NF-[kappa]B in osteoclast and B-cell development JA - Genes Dev. PY - 1997/// VL - 11 SP - 3482 EP - 3496 ER - TY - JOUR AU - Xing, L. TI - NF-[kappa]B p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis JA - J. Bone Miner. Res. PY - 2002/// VL - 17 SP - 1200 EP - 1210 ER - TY - JOUR AU - Grigoriadis, A. E. TI - c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling JA - Science PY - 1994/// VL - 266 SP - 443 EP - 448 ER - TY - JOUR AU - Karin, M. AU - Cao, Y. AU - Greten, F. R. AU - Li, Z.-W. TI - NF-[kappa]B in cancer: from an innocent bystander to major culprit JA - Nature Rev. Cancer PY - 2002/// VL - 2 SP - 301 EP - 310 M3 - 10.1038/nrc780 N1 - 10.1038/nrc780 UR - http://dx.doi.org/10.1038/nrc780 ER - TY - JOUR AU - David, J. P. AU - Sabapathy, K. AU - Hoffmann, O. AU - Idarraga, M. H. AU - Wagner, E. F. TI - JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms JA - J. Cell Sci. PY - 2002/// VL - 115 SP - 4317 EP - 4325 M3 - 10.1242/jcs.00082 N1 - 10.1242/jcs.00082 UR - http://dx.doi.org/10.1242/jcs.00082 ER - TY - JOUR AU - Lee, S. W. AU - Han, S. I. AU - Kim, H. H. AU - Lee, Z. H. TI - TAK1-dependent activation of AP-1 and c-Jun N-terminal kinase by receptor activator of NF-[kappa]B JA - J. Biochem. Mol. Biol. PY - 2002/// VL - 35 SP - 371 EP - 376 ER - TY - JOUR AU - Mizukami, J. TI - Receptor activator of NF-[kappa]B ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6 JA - Mol. Cell. Biol. PY - 2002/// VL - 22 SP - 992 EP - 1000 M3 - 10.1128/MCB.22.4.992-1000.2002 N1 - 10.1128/MCB.22.4.992-1000.2002 UR - http://dx.doi.org/10.1128/MCB.22.4.992-1000.2002 ER - TY - JOUR AU - Oda, H. AU - Nakamura, K. AU - Tanaka, S. TI - Possible involvement of I[kappa]B kinase 2 and MKK7 in osteoclastogenesis induced by receptor activator of nuclear factor [kappa]B ligand JA - J. Bone Miner. Res. PY - 2002/// VL - 17 SP - 612 EP - 621 ER - TY - JOUR AU - Li, X. TI - p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function JA - Endocrinology PY - 2002/// VL - 143 SP - 3105 EP - 3113 M3 - 10.1210/en.143.8.3105 N1 - 10.1210/en.143.8.3105 UR - http://dx.doi.org/10.1210/en.143.8.3105 ER - TY - JOUR AU - Matsumoto, M. AU - Sudo, T. AU - Saito, T. AU - Osada, H. AU - Tsujimoto, M. TI - Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-[kappa]B ligand (RANKL) JA - J. Biol. Chem. PY - 2000/// VL - 275 SP - 31155 EP - 31161 M3 - 10.1074/jbc.M001229200 N1 - 10.1074/jbc.M001229200 UR - http://dx.doi.org/10.1074/jbc.M001229200 ER - TY - JOUR AU - Mansky, K. C. AU - Sankar, U. AU - Han, J. AU - Ostrowski, M. C. TI - Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-[kappa]B ligand signaling JA - J. Biol. Chem. PY - 2002/// VL - 277 SP - 11077 EP - 11083 M3 - 10.1074/jbc.M111696200 N1 - 10.1074/jbc.M111696200 UR - http://dx.doi.org/10.1074/jbc.M111696200 ER - TY - JOUR AU - Wei, S. AU - Wang, M. W. AU - Teitelbaum, S. L. AU - Ross, F. P. TI - Interleukin-4 reversibly inhibits osteoclastogenesis via inhibition of NF-[kappa]B and mitogen-activated protein kinase signaling JA - J. Biol. Chem. PY - 2002/// VL - 277 SP - 6622 EP - 6630 M3 - 10.1074/jbc.M104957200 N1 - 10.1074/jbc.M104957200 UR - http://dx.doi.org/10.1074/jbc.M104957200 ER - TY - JOUR AU - Hotokezaka, H. TI - U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells JA - J. Biol. Chem. PY - 2002/// VL - 277 SP - 47366 EP - 47372 M3 - 10.1074/jbc.M208284200 N1 - 10.1074/jbc.M208284200 UR - http://dx.doi.org/10.1074/jbc.M208284200 ER - TY - JOUR AU - Wong, B. R. TI - TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src JA - Mol. Cell PY - 1999/// VL - 4 SP - 1041 EP - 1049 M3 - 10.1016/S1097-2765(00)80232-4 N1 - 10.1016/S1097-2765(00)80232-4 UR - http://dx.doi.org/10.1016/S1097-2765(00)80232-4 ER - TY - JOUR AU - Shui, C. AU - Riggs, B. L. AU - Khosla, S. TI - The immunosuppressant rapamycin, alone or with transforming growth factor-[beta], enhances osteoclast differentiation of RAW264.7 monocyte-macrophage cells in the presence of RANK-ligand JA - Calcif. Tissue Int. PY - 2002/// VL - 71 SP - 437 EP - 446 M3 - 10.1007/s00223-001-1138-3 N1 - 10.1007/s00223-001-1138-3 UR - http://dx.doi.org/10.1007/s00223-001-1138-3 ER - TY - JOUR AU - Cappellen, D. TI - Transcriptional program of mouse osteoclast differentiation governed by the macrophage colony-stimulating factor and the ligand for the receptor activator of NF[kappa]B JA - J. Biol. Chem. PY - 2002/// VL - 277 SP - 21971 EP - 21982 M3 - 10.1074/jbc.M200434200 N1 - 10.1074/jbc.M200434200 UR - http://dx.doi.org/10.1074/jbc.M200434200 ER - TY - JOUR AU - Ishida, N. TI - Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator JA - J. Biol. Chem. PY - 2002/// VL - 277 SP - 41147 EP - 41156 M3 - 10.1074/jbc.M205063200 N1 - 10.1074/jbc.M205063200 UR - http://dx.doi.org/10.1074/jbc.M205063200 ER - TY - JOUR AU - Takayanagi, H. TI - Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts JA - Dev. Cell PY - 2002/// VL - 3 SP - 889 EP - 901 M3 - 10.1016/S1534-5807(02)00369-6 N1 - 10.1016/S1534-5807(02)00369-6 UR - http://dx.doi.org/10.1016/S1534-5807(02)00369-6 ER - TY - JOUR AU - Battaglino, R. TI - c-myc is required for osteoclast differentiation JA - J. Bone Miner. Res. PY - 2002/// VL - 17 SP - 763 EP - 773 ER - TY - JOUR AU - Mak, T. W. AU - Yeh, W. C. TI - A block at the toll gate JA - Nature PY - 2002/// VL - 418 SP - 835 EP - 836 M3 - 10.1038/418835a N1 - 10.1038/418835a UR - http://dx.doi.org/10.1038/418835a ER - TY - JOUR AU - Arai, F. TI - Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor [kappa]B (RANK) receptors JA - J. Exp. Med. PY - 1999/// VL - 190 SP - 1741 EP - 1754 M3 - 10.1084/jem.190.12.1741 N1 - 10.1084/jem.190.12.1741 UR - http://dx.doi.org/10.1084/jem.190.12.1741 ER - TY - JOUR AU - Yan, T. AU - Riggs, B. L. AU - Boyle, W. J. AU - Khosla, S. TI - Regulation of osteoclastogenesis and RANK expression by TGF-[beta]1 JA - J. Cell. Biochem. PY - 2001/// VL - 83 SP - 320 EP - 325 M3 - 10.1002/jcb.1200 N1 - 10.1002/jcb.1200 UR - http://dx.doi.org/10.1002/jcb.1200 ER - TY - JOUR AU - Ma, Y. L. TI - Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation JA - Endocrinology PY - 2001/// VL - 142 SP - 4047 EP - 4054 M3 - 10.1210/en.142.9.4047 N1 - 10.1210/en.142.9.4047 UR - http://dx.doi.org/10.1210/en.142.9.4047 ER - TY - JOUR AU - Takayanagi, H. TI - RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-[beta] JA - Nature PY - 2002/// VL - 416 SP - 744 EP - 749 M3 - 10.1038/416744a N1 - 10.1038/416744a UR - http://dx.doi.org/10.1038/416744a ER - TY - JOUR AU - Hayashi, T. AU - Kaneda, T. AU - Toyama, Y. AU - Kumegawa, M. AU - Hakeda, Y. TI - Regulation of receptor activator of NF-[kappa]B ligand-induced osteoclastogenesis by endogenous interferon-[beta] (INF-[beta]) and suppressors of cytokine signaling (SOCS). The possible counteracting role of SOCSs in IFN-[beta]-inhibited osteoclast formation JA - J. Biol. Chem. PY - 2002/// VL - 277 SP - 27880 EP - 27886 M3 - 10.1074/jbc.M203836200 N1 - 10.1074/jbc.M203836200 UR - http://dx.doi.org/10.1074/jbc.M203836200 ER - TY - JOUR AU - Takayanagi, H. TI - T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-[gamma] JA - Nature PY - 2000/// VL - 408 SP - 600 EP - 605 M3 - 10.1038/35046102 N1 - 10.1038/35046102 UR - http://dx.doi.org/10.1038/35046102 ER - TY - JOUR AU - Kong, Y. Y. TI - Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand JA - Nature PY - 1999/// VL - 402 SP - 304 EP - 309 M3 - 10.1038/46303 N1 - 10.1038/46303 UR - http://dx.doi.org/10.1038/46303 ER - TY - JOUR AU - Chagraoui, H. TI - Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO JA - Blood ER - TY - JOUR AU - Hughes, A. E. TI - Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis JA - Nature Genet. PY - 2000/// VL - 24 SP - 45 EP - 48 M3 - 10.1038/71667 N1 - 10.1038/71667 UR - http://dx.doi.org/10.1038/71667 ER - TY - JOUR AU - Whyte, M. P. AU - Hughes, A. E. TI - Expansile skeletal hyperphosphatasia is caused by a 15-base pair tandem duplication in TNFRSF11A encoding RANK and is allelic to familial expansile osteolysis JA - J. Bone Miner. Res. PY - 2002/// VL - 17 SP - 26 EP - 29 ER - TY - JOUR AU - Whyte, M. P. TI - Osteoprotegerin deficiency and juvenile Paget's disease JA - N. Engl. J. Med. PY - 2002/// VL - 347 SP - 175 EP - 184 M3 - 10.1056/NEJMoa013096 N1 - 10.1056/NEJMoa013096 UR - http://dx.doi.org/10.1056/NEJMoa013096 ER - TY - JOUR AU - Cundy, T. TI - A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype JA - Hum. Mol. Genet. PY - 2002/// VL - 11 SP - 2119 EP - 2127 M3 - 10.1093/hmg/11.18.2119 N1 - 10.1093/hmg/11.18.2119 UR - http://dx.doi.org/10.1093/hmg/11.18.2119 ER - TY - JOUR AU - Langdahl, B. L. AU - Carstens, M. AU - Stenkjaer, L. AU - Eriksen, E. F. TI - Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures JA - J. Bone Miner. Res. PY - 2002/// VL - 17 SP - 1245 EP - 1255 ER - TY - JOUR AU - Bekker, P. J. TI - The effect of a single dose of osteoprotegerin in postmenopausal women JA - J. Bone Miner. Res. PY - 2001/// VL - 16 SP - 348 EP - 360 ER - TY - JOUR AU - Body, J. J. TI - A Phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases JA - Cancer PY - 2003/// VL - 97 IS - Suppl. SP - 887 EP - 892 M3 - 10.1002/cncr.11138 N1 - 10.1002/cncr.11138 UR - http://dx.doi.org/10.1002/cncr.11138 ER - TY - JOUR AU - Eghbali-Fatourechi, G. TI - Role of RANK ligand in mediating the increased bone resorption in early postmenopausal women JA - J. Clin. Invest. PY - 2003/// VL - 111 SP - 1221 EP - 1230 M3 - 10.1172/JCI200317215 N1 - 10.1172/JCI200317215 UR - http://dx.doi.org/10.1172/JCI200317215 ER - TY - JOUR AU - Kim, Y. H. AU - Kim, G. S. AU - Jeong-Hwa, B. TI - Inhibitory action of bisphosphonates on bone resorption does not involve the regulation of RANKL and OPG expression JA - Exp. Mol. Med. PY - 2002/// VL - 34 SP - 145 EP - 151 ER - TY - JOUR AU - Mizuno, A. TI - Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis JA - J. Bone Miner. Metab. PY - 2002/// VL - 20 SP - 337 EP - 344 M3 - 10.1007/s007740200049 N1 - 10.1007/s007740200049 UR - http://dx.doi.org/10.1007/s007740200049 ER -